The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Does N-3 LCPUFA Supplementation In Pregnancy Reduce Asthma And Allergies In School Age Children?
Funder
National Health and Medical Research Council
Funding Amount
$443,833.00
Summary
We will determine whether supplementing the diets of pregnant women with fish oil can have long term effects on the development of the childÍs immune system and reduce the prevalence of asthma and allergies at early school age. The outcomes of our project will inform nutritional guidelines for pregnant women and, if successful, has the potential to significantly lower the costly burden of childhood asthma and allergies to families and the healthcare system.
The Effects Of Omega-3 Fatty Acids On Novel Anti-Inflammatory Metabolites And Telomere Length In Early And Later Life: Potential Implications For Long-Term Cardiovascular Risk
Funder
National Health and Medical Research Council
Funding Amount
$870,091.00
Summary
Exciting new effects of omega-3 fats from fish oil have recently been discovered which actively reduce inflammation and help prolong cell life. These mechanisms are relevant to the risk of complications of obesity and cardiovascular disease. We will study the effects of fish oil given in pregnancy, infancy and later in life, with a view to using omega-3 fatty acid supplements for both early prevention and later treatment of obesity and cardiovascular disease.
Efficacy And Safety Of Omega-3 DHA Supplementation In Preterm Infants: Childhood Follow-up Of The N3RO Trial.
Funder
National Health and Medical Research Council
Funding Amount
$713,218.00
Summary
Giving babies born 3 to 4 months prematurely the omega-3 DHA has been thought to improve their mental development. But we don’t yet know if this is indeed so. In this follow-up study, we will be able to find out the important longer-term effects at 5-years of age of extra DHA in the first months of life by assessing the children’s mental development.
Reducing Cardiovascular Risk In Children Born With Poor Fetal Growth: The Small Baby Omega-3 (SO3) Trial
Funder
National Health and Medical Research Council
Funding Amount
$999,791.00
Summary
Poor fetal growth affects about 10% of people, and is a risk factor for high blood pressure and heart disease in adults. There is no current treatment to reduce the increased risk of heart disease due to poor fetal growth. This study will determine whether taking fish oils during infancy reduces arterial wall thickness, a sign of the disease that causes the majority of heart attacks, and lowers blood pressure in children who had poor fetal growth.
The Aboriginal Cardiovascular Omega-3 Randomised Controlled Trial
Funder
National Health and Medical Research Council
Funding Amount
$1,090,119.00
Summary
CVD is the primary contributor to life expectancy differentials between Indigenous and non-Indigenous Australians. Even when cardioprotective therapies are optimally used, residual risk of adverse events is often observed. Testing of additional therapies that improve survival among Indigenous people with CVD is required. Omega 3 fatty acids can improve multiple atherogenic pathways. This trial will assess the impact of Omega 3 in Aboriginal patients with CVD.
A Selective Prevention Trial Using Novel Pharmacotherapies In An Older Age Cohort At Risk For Depression
Funder
National Health and Medical Research Council
Funding Amount
$975,259.00
Summary
The study will examine whether omega-3 fatty acids or antidepressants prevent the onset of depression in a group of older community participants who have previously been identified as being "at risk" of depression. The study will incorporate sophisticated brain scanning methods, as well as tests of brain functioning to determine acute brain changes, reduction in cognitive decline and prevention of depression over a one-year period.
Mechanisms Of Impaired Bronchodilator Response Associated With Fatty Acid Intake In Obese Asthma
Funder
National Health and Medical Research Council
Funding Amount
$694,365.00
Summary
Obese asthmatics typically have a high dietary fat intake, which reduces the efficacy of their asthma medications. We will determine which types of dietary fat affect asthma medications. We will also determine which asthma medications are affected by a high fat load. Finally, we will examine the mechanisms by which fatty acids affect the efficacy of asthma medications. This is will inform new treatment options for managing the many obese asthmatics who are not able to achieve weight loss.
Erythrocyte Membrane Fatty Acid Concentrations And Myelin Integrity In Young People At Ultra-High Risk Of Psychosis
Funder
National Health and Medical Research Council
Funding Amount
$406,831.00
Summary
Polyunsaturated fatty acids (PUFAs) play an important role in many physiological processes in all organisms. Myelination is the process by which a fatty layer, called myelin, accumulates around nerve cells enabling nerve cells to transmit information faster. PUFAs are essential for myelination, and there is evidence documenting decreased PUFA concentrations and brain white matter (myelin) pathology in people with schizophrenia. The mechanisms underlying these abnormalities are not understood.
Impaired Respiratory Tolerance In Obesity - The Link With Asthma?
Funder
National Health and Medical Research Council
Funding Amount
$667,294.00
Summary
Australia has one of the highest obesity rates in the world, placing a major strain on health budgets. Obesity increases the risk of numerous diseases, including asthma. Asthma is prevented in healthy people by the immune system. This project will investigate whether obesity-related dietary factors and/or gut microbes impair this immune-mediated mechanism. Outcomes will increase understanding of the effects of diet and obesity on asthma development, and lead to novel asthma therapies.
Treating Hyperglycaemia In Diabetes With Polyunsaturated Fatty Acid Analogues
Funder
National Health and Medical Research Council
Funding Amount
$602,260.00
Summary
Diabetes, characterised by elevated blood glucose, has a major impact on affected children, their families and the community. Our preliminary evidence suggests that a newly developed polyunsaturated fatty acid normalises blood glucose levels in an experimental diabetes model. This research will attempt to provide evidence that we have discovered a fat which has insulin like action and which may be taken orally once every 3-4 days to treat the elevated blood glucose.